Cargando…

Altered glycosylation of glycodelin in endometrial carcinoma

Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hautala, Laura C., Pang, Poh-Choo, Antonopoulos, Aristotelis, Pasanen, Annukka, Lee, Cheuk-Lun, Chiu, Philip C. N., Yeung, William S. B., Loukovaara, Mikko, Bützow, Ralf, Haslam, Stuart M., Dell, Anne, Koistinen, Hannu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312397/
https://www.ncbi.nlm.nih.gov/pubmed/32205858
http://dx.doi.org/10.1038/s41374-020-0411-x
_version_ 1783549718710714368
author Hautala, Laura C.
Pang, Poh-Choo
Antonopoulos, Aristotelis
Pasanen, Annukka
Lee, Cheuk-Lun
Chiu, Philip C. N.
Yeung, William S. B.
Loukovaara, Mikko
Bützow, Ralf
Haslam, Stuart M.
Dell, Anne
Koistinen, Hannu
author_facet Hautala, Laura C.
Pang, Poh-Choo
Antonopoulos, Aristotelis
Pasanen, Annukka
Lee, Cheuk-Lun
Chiu, Philip C. N.
Yeung, William S. B.
Loukovaara, Mikko
Bützow, Ralf
Haslam, Stuart M.
Dell, Anne
Koistinen, Hannu
author_sort Hautala, Laura C.
collection PubMed
description Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a less malignant phenotype. Here we aimed to elucidate whether the glycosylation and function of glycodelin is altered in endometrial carcinoma as compared with a normal endometrium. We carried out glycan structure analysis of glycodelin expressed in HEC-1B human endometrial carcinoma cells (HEC-1B Gd) by mass spectrometry glycomics strategies. Glycans of HEC-1B Gd were found to comprise a typical mixture of high-mannose, hybrid, and complex-type N-glycans, often containing undecorated LacNAc (Galβ1–4GlcNAc) antennae. However, several differences, as compared with previously reported glycan structures of normal human decidualized endometrium-derived glycodelin isoform, glycodelin-A (GdA), were also found. These included a lower level of sialylation and more abundant poly-LacNAc antennae, some of which are fucosylated. This allowed us to select lectins that showed different binding to these classes of glycodelin. Despite the differences in glycosylation between HEC-1B Gd and GdA, both showed similar inhibitory activity on trophoblast cell invasion and peripheral blood mononuclear cell proliferation. For the detection of cancer associated glycodelin, we established a novel in situ proximity-ligation based histochemical staining method using a specific glycodelin antibody and UEAI lectin. We found that the UEAI reactive glycodelin was abundant in endometrial carcinoma, but virtually absent in normal endometrial tissue even when glycodelin was strongly expressed. In conclusion, we established a histochemical staining method for the detection of endometrial carcinoma-associated glycodelin and showed that this specific glycodelin is exclusively expressed in cancer, not in normal endometrium. Similar methods can be used for studies of other glycoproteins.
format Online
Article
Text
id pubmed-7312397
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-73123972020-06-26 Altered glycosylation of glycodelin in endometrial carcinoma Hautala, Laura C. Pang, Poh-Choo Antonopoulos, Aristotelis Pasanen, Annukka Lee, Cheuk-Lun Chiu, Philip C. N. Yeung, William S. B. Loukovaara, Mikko Bützow, Ralf Haslam, Stuart M. Dell, Anne Koistinen, Hannu Lab Invest Technical Report Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a less malignant phenotype. Here we aimed to elucidate whether the glycosylation and function of glycodelin is altered in endometrial carcinoma as compared with a normal endometrium. We carried out glycan structure analysis of glycodelin expressed in HEC-1B human endometrial carcinoma cells (HEC-1B Gd) by mass spectrometry glycomics strategies. Glycans of HEC-1B Gd were found to comprise a typical mixture of high-mannose, hybrid, and complex-type N-glycans, often containing undecorated LacNAc (Galβ1–4GlcNAc) antennae. However, several differences, as compared with previously reported glycan structures of normal human decidualized endometrium-derived glycodelin isoform, glycodelin-A (GdA), were also found. These included a lower level of sialylation and more abundant poly-LacNAc antennae, some of which are fucosylated. This allowed us to select lectins that showed different binding to these classes of glycodelin. Despite the differences in glycosylation between HEC-1B Gd and GdA, both showed similar inhibitory activity on trophoblast cell invasion and peripheral blood mononuclear cell proliferation. For the detection of cancer associated glycodelin, we established a novel in situ proximity-ligation based histochemical staining method using a specific glycodelin antibody and UEAI lectin. We found that the UEAI reactive glycodelin was abundant in endometrial carcinoma, but virtually absent in normal endometrial tissue even when glycodelin was strongly expressed. In conclusion, we established a histochemical staining method for the detection of endometrial carcinoma-associated glycodelin and showed that this specific glycodelin is exclusively expressed in cancer, not in normal endometrium. Similar methods can be used for studies of other glycoproteins. Nature Publishing Group US 2020-03-23 2020 /pmc/articles/PMC7312397/ /pubmed/32205858 http://dx.doi.org/10.1038/s41374-020-0411-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Technical Report
Hautala, Laura C.
Pang, Poh-Choo
Antonopoulos, Aristotelis
Pasanen, Annukka
Lee, Cheuk-Lun
Chiu, Philip C. N.
Yeung, William S. B.
Loukovaara, Mikko
Bützow, Ralf
Haslam, Stuart M.
Dell, Anne
Koistinen, Hannu
Altered glycosylation of glycodelin in endometrial carcinoma
title Altered glycosylation of glycodelin in endometrial carcinoma
title_full Altered glycosylation of glycodelin in endometrial carcinoma
title_fullStr Altered glycosylation of glycodelin in endometrial carcinoma
title_full_unstemmed Altered glycosylation of glycodelin in endometrial carcinoma
title_short Altered glycosylation of glycodelin in endometrial carcinoma
title_sort altered glycosylation of glycodelin in endometrial carcinoma
topic Technical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312397/
https://www.ncbi.nlm.nih.gov/pubmed/32205858
http://dx.doi.org/10.1038/s41374-020-0411-x
work_keys_str_mv AT hautalalaurac alteredglycosylationofglycodelininendometrialcarcinoma
AT pangpohchoo alteredglycosylationofglycodelininendometrialcarcinoma
AT antonopoulosaristotelis alteredglycosylationofglycodelininendometrialcarcinoma
AT pasanenannukka alteredglycosylationofglycodelininendometrialcarcinoma
AT leecheuklun alteredglycosylationofglycodelininendometrialcarcinoma
AT chiuphilipcn alteredglycosylationofglycodelininendometrialcarcinoma
AT yeungwilliamsb alteredglycosylationofglycodelininendometrialcarcinoma
AT loukovaaramikko alteredglycosylationofglycodelininendometrialcarcinoma
AT butzowralf alteredglycosylationofglycodelininendometrialcarcinoma
AT haslamstuartm alteredglycosylationofglycodelininendometrialcarcinoma
AT dellanne alteredglycosylationofglycodelininendometrialcarcinoma
AT koistinenhannu alteredglycosylationofglycodelininendometrialcarcinoma